Progress of metformin for treatment of blood cancers

doi:10.3969/j.issn.2097-0005.2021.11.017

Abstract

Abstract:

Metformin is a first line drug of therapy for type 2 diabetes mellitus. Recently more and more evidence indicates that metformin use has been found to be connected with a reduced incidence of cancer and cancer-related mortality in patients with or without diabetes. Moreover， studies indicate that metformin can also be used as a therapeutic agent in patients with leukemia， lymphomas and multiple myeloma. In this article， we review current treatments on the anticancer activities of metformin and the underlying mechanisms in blood cancers.

Key words: metformin, diabetes, blood cancers, myeloma, leukemia, lymphoma

摘要：

二甲双胍是治疗2型糖尿病的一线药物。目前越来越多的证据表明，二甲双胍可以降低糖尿病或非糖尿病患者的癌症发病率和癌症相关的病死率。而且研究表明二甲双胍还可作为白血病、淋巴瘤和多发性骨髓瘤患者的治疗药物。在此篇文章中，我们回顾了目前关于二甲双胍在血液肿瘤中的应用现状和其可能的抗癌机制。

关键词: 二甲双胍, 糖尿病, 血液肿瘤, 骨髓瘤, 白血病, 淋巴瘤

CLC Number:

R733

Shiquan Ding, Ling Wang. Progress of metformin for treatment of blood cancers[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(11): 876-880.

丁世权, 王玲. 二甲双胍治疗血液肿瘤的研究进展[J]. betway必威登陆网址（betway.com ）学报, 2021, 42(11): 876-880.

References 39

1	Han TJ， Li JS， Luan XT， et al. Dietary fat consumption and non-Hodgkin's lymphoma risk： a meta-analysis［J］. Nutr Cancer， 2017， 69（2）： 221.
2	Han TJ， Xu HZ， Li JS， et al. Leptin and its receptor in glucose metabolism of T-cell lymphoma［J］. Oncol Lett， 2018， 16（5）： 5838.
3	Han TJ， Wang X. Leptin and its receptor in hematologic malignancies［J］. Int J Clin Exp Med， 2015， 8（11）： 19840.
4	Wojciechowska J， Krajewski W， Bolanowski M， et al. Diabetes and cancer： a review of current knowledge［J］. Exp Clin Endocrinol Diabetes， 2016， 124（5）： 263.
5	Zhang ZJ， Li S. The prognostic value of metformin for cancer patients with concurrent diabetes： a systematic review and meta-analysis［J］. Diabetes Obes Metab， 2014， 16（8）： 707.
6	张曦，饶军. 血液肿瘤的精准诊治［J］. 第三军医大学学报， 2020， 42（17）： 1675.
7	郭一萌，杨静，严虹霞，等. 二甲双胍对乳腺癌患者预后影响的Meta分析［J］. 肿瘤研究与临床， 2019， 31（1）： 41.
8	Rodríguez-Lirio A， Pérez-Yarza G， Fernández-Suárez MR， et al. Metformin induces cell cycle arrest and apoptosis in drug-resistant leukemia cells［J］. Leuk Res Treatment， 2015， 2015： 516460.
9	Ramos Peñafiel C， Olarte Carrillo I， Ceron Maldonado R， et al. Effect of metformin added to chemotherapy on the survival of patients with acute lymphoblastic leukemia［J］. Rev Med Chil， 2018， 146（7）： 846.
10	Olarte Carrillo I， Ramos Peñafiel C， Miranda Peralta E， et al. Clinical significance of the ABCB₁ and ABCG2 gene expression levels in acute lymphoblastic leukemia［J］. Hematology， 2017， 22（5）： 286.
11	Ramos-Peñafiel C， Olarte-Carrillo I， Cerón-Maldonado R， et al. Effect of metformin on the survival of patients with ALL who express high levels of the ABCB₁ drug resistance gene［J］. J Transl Med， 2018， 16（1）： 245.
12	Trucco M， Barredo JC， Goldberg J， et al. A phase Ⅰ window， dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia： Metformin with induction chemotherapy of vincristine， dexamethasone， PEG-asparaginase， and doxorubicin［J］. Pediatr Blood Cancer， 2018， 65（9）： e27224.
13	陈惠丽，马平，陈艳丽，等. 二甲双胍对K562细胞增殖、凋亡及糖酵解的影响［J］. 中国实验血液学杂志， 2019， 27（5）： 1387.
14	Na YJ， Yu ES， Kim DS， et al. Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells［J］. Korean J Intern Med， 2021， 36（）： S196.
15	Shi R， Lin J， Gong Y， et al. The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell［J］. Anticancer Drugs， 2015， 26（9）： 913.
16	Renner K， Seilbeck A， Kauer N， et al. Combined metabolic targeting with metformin and the NSAIDs diflunisal and diclofenac induces apoptosis in acute myeloid leukemia cells［J］. Front Pharmacol， 2018， 9： 1258.
17	Huai L， Wang CC， Zhang CP， et al. Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway［J］. Biochem Biophys Res Commun， 2012， 422（3）： 398.
18	Adekola KU， Dalva Aydemir S， Ma S， et al. Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin［J］. Leuk Lymphoma， 2015， 56（2）： 450.
19	Bruno S， Ledda B， Tenca C， et al. Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells［J］. Oncotarget， 2015， 6（26）： 22624.
20	Rosilio C， Ben-Sahra I， Bost F， et al. Metformin： a metabolic disruptor and anti-diabetic drug to target human leukemia［J］. Cancer Lett， 2014， 346（2）： 188.
21	卢博，桂书彦，周欢欢，等. 二甲双胍抑制多发性骨髓瘤细胞增殖作用的实验研究［J］. 中国实验血液学杂志， 2017； 25（4）： 1097.
22	仝佳音，王冲，刘延方，等. 二甲双胍通过线粒体途径诱导人骨髓瘤细胞株U266细胞凋亡［J］. 中国实验血液学杂志， 2018， 26（2）： 489.
23	Kocemba-Pilarczyk KA， Trojan S， Ostrowska B， et al. Influence of metformin on HIF-1 pathway in multiple myeloma［J］. Pharmacol Rep， 2020， 72（5）： 1407.
24	Jagannathan S， Abdel-Malek MAY， Malek E， et al. Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib［J］. Leukemia， 2015， 29（11）： 2184.
25	Chang SH， Luo SH， O'Brian KK， et al. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus： a population-based retrospective cohort study［J］. Lancet Haematol， 2015， 2（1）： e30.
26	Wang W， Guan KL. AMP-activated protein kinase and cancer［J］. Acta Physiol， 2009， 196（1）： 55.
27	Wang Y， Xu W， Yan Z， et al. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways［J］. J Exp Clin Cancer Res， 2018， 37（1）： 63.
28	Zi FM， He JS， Li Y， et al. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models［J］. Cancer Lett， 2015， 356（2）： 443.
29	Mishra AK， Dingli D. Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells［J］. Leukemia， 2019， 33（11）： 2695.
30	Weiss BM， de Abadie J， Verma P， et al. A monoclonal gammopathy precedes multiple myeloma in most patients［J］. Blood， 2009， 113（22）： 5418.
31	Landgren O， Kyle RA， Pfeiffer RM， et al. Monoclonal gammopathy of undetermined significance （MGUS） consistently precedes multiple myeloma： a prospective study［J］. Blood， 2009， 113（22）： 5412.
32	Kyle RA， Therneau TM， Rajkumar SV， et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance［J］. N Engl J Med， 2002， 346（8）： 564.
33	Boursi B， Mamtani R， Yang YX， et al. Impact of metformin on the progression of MGUS to multiple myeloma［J］. Leuk Lymphoma， 2017， 58（5）： 1265.
34	Shi WY， Xiao D， Wang L， et al. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy［J］. Cell Death Dis， 2012， 3（3）： e275.
35	Chukkapalli V， Gordon LI， Venugopal P， et al. Metabolic changes associated with metformin potentiates Bcl-2 inhibitor， Venetoclax， and CDK9 inhibitor， BAY1143572 and reduces viability of lymphoma cells［J］. Oncotarget， 2018， 9（30）： 21166.
36	Naserian M， Ramazani E， Iranshahi M， et al. The role of SAPK/JNK pathway in the synergistic effects of metformin and dacarbazine on apoptosis in raji and Ramos lymphoma cells［J］. Curr Mol Pharmacol， 2018， 11（4）： 336.
37	Tseng CH. Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes［J］. Diabetes Metab， 2019， 45（5）： 458.
38	Alkhatib Y， Abdel Rahman Z， Kuriakose P. Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients： a case-control study［J］. Leuk Lymphoma， 2017， 58（5）： 1130.
39	Singh AR， Gu JJ， Zhang Q， et al. Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma［J］. Cancer Metab， 2020， 8： 10.

[1]	Lixia Shi. The effect of one day outpatient on patients with gestational diabetes mellitus [J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(8): 606-609.
[2]	Yingying Zhang, Chong Zhang, Long Zang. The clinical efficacy of metformin combined with diet control exercise therapy in the treatment of community diabetes with high BMI [J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(8): 584-587.
[3]	Jianhua Chen, Ruimin Tian, Lijun Luo, Chunlei Yu. Prevalence of cardiovascular comorbidities in severe acute respiratory syndrome coronavirus 2（SARS-CoV-2）： a systematic review and Meta-analysis [J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(7): 525-533.
[4]	Zhao Mengqiu, Ren Younan, Tao Shanjun, Zheng Shuguo. Effect of salvianolic acid B on improving myocardium injury in diabetic rats with blood glucose fluctuation [J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(5): 369-374.
[5]	FU Li-wu, YOU Bin. The diagnostic value and characteristics of PET combined with CT in diffuse large B-cell lymphoma (DLBCL) [J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(4): 305-307.
[6]	Ping Yuan, Xu Zhang, Baolu Tang, Xiaoyu Qi, Mingyue Ma, Shuguo Zheng. Effect of Sijunzi granules on STC-1 cell apoptosis induced by palmitic acid [J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2021, 42(11): 801-806.